首页> 外文期刊>Cancer biology & therapy >Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.
【24h】

Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.

机译:结直肠肿瘤发生的鸟苷酸环化酶C信号传导途径中的稳态机制的破坏。

获取原文
获取原文并翻译 | 示例
           

摘要

Colon cancer, the second leading cause of cancer-related mortality worldwide, originates from the malignant transformation of intestinal epithelial cells. The intestinal epithelium undergoes a highly organized process of rapid regeneration along the crypt-villus axis, characterized by proliferation, migration, differentiation and apoptosis, whose coordination is essential to maintaining the mucosal barrier. Disruption of these homeostatic processes predisposes cells to mutations in tumor suppressors or oncogenes, whose dysfunction provides transformed cells an evolutionary growth advantage. While sequences of genetic mutations at different stages along the neoplastic continuum have been established, little is known of the events initiating tumorigenesis prior to adenomatous polyposis coli (APC) mutations. Here, we examine a role for the corruption of homeostasis induced by silencing novel tumor suppressors, including the intestine-specific transcription factor CDX2 and its gene target guanylyl cyclase C (GCC), as early events predisposing cells to mutations in APC and other sequential genes that initiate colorectal cancer. CDX2 and GCC maintain homeostatic regeneration in the intestine by restricting cell proliferation, promoting cell maturation and adhesion, regulating cell migration and defending the intestinal barrier and genomic integrity. Elimination of CDX2 or GCC promotes intestinal tumor initiation and growth in aged mice, mice carrying APC mutations or mice exposed to carcinogens. The roles of CDX2 and GCC in suppressing intestinal tumorigenesis, universal disruption in their signaling through silencing of hormones driving GCC, and the uniform overexpression of GCC by tumors underscore the potential value of oral replacement with GCC ligands as targeted prevention and therapy for colorectal cancer.
机译:结肠癌是全球范围内与癌症相关的死亡率的第二大诱因,源于肠道上皮细胞的恶性转化。肠道上皮沿着隐窝-绒毛轴经历了高度组织化的快速再生过程,其特征在于增殖,迁移,分化和凋亡,它们的协调对于维持粘膜屏障至关重要。这些稳态过程的破坏使细胞易于发生肿瘤抑制基因或致癌基因的突变,其功能障碍为转化细胞提供了进化生长优势。虽然已经建立了沿肿瘤连续体不同阶段的基因突变序列,但对腺瘤性息肉病大肠杆菌(APC)突变之前引发肿瘤发生的事件知之甚少。在这里,我们研究了通过沉默新型肿瘤抑制因子(包括肠特异性转录因子CDX2及其基因靶标鸟苷酰环化酶C(GCC))而导致的稳态破坏的作用,因为早期事件使细胞易于发生APC和其他顺序基因的突变引发大肠癌。 CDX2和GCC通过限制细胞增殖,促进细胞成熟和粘附,调节细胞迁移并捍卫肠道屏障和基因组完整性来维持肠道的稳态再生。消除CDX2或GCC可以促进老年小鼠,携带APC突变的小鼠或暴露于致癌物的小鼠肠道肿瘤的发生和生长。 CDX2和GCC在抑制肠道肿瘤发生,通过驱动GCC的激素沉默引起的信号传导普遍破坏以及肿瘤均匀地过度表达GCC中的作用突显出口服GCC配体替代结肠直肠癌的潜在价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号